Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Search by expertise, name or affiliation
Oltipraz: A laboratory and clinical review
Al B. Benson
*
*
Corresponding author for this work
Medicine, Hematology Oncology Division
Research output
:
Contribution to journal
›
Article
›
peer-review
77
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Oltipraz: A laboratory and clinical review'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Chemical Compounds
Oltipraz
100%
Dose
26%
Detoxification
9%
Schistosomicide Agent
8%
Maximum Tolerated Dose
7%
Chemoprotective
7%
Adduct
6%
Chemopreventive
6%
Peak Plasma Concentration
5%
Photosensitivity
5%
Aflatoxin
5%
Inducer
5%
Medicine & Life Sciences
oltipraz
88%
Carcinogenesis
12%
Brassica
10%
Schistosomicides
7%
Phase II Metabolic Detoxication
6%
Liver
6%
Endpoint Determination
6%
Phototoxic Dermatitis
5%
Aflatoxins
5%
Clinical Trials
5%
Breast Neoplasms
5%
Hepatobiliary Elimination
5%